CLASS II Device recall · Reported 2 Dec 2020 · FDA Enforcement Report

Geistlich Bio-Oss Pen recalled by Geistlich Pharma North America

Geistlich Pharma North America is recalling Geistlich Bio-Oss Pen 25, distributed nationwide in the US. The recall was initiated on 19 Oct 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: 81901650, 82000456
Quantity recalled1759 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0490-2021
FDA event ID
86628
Recalling firm
Geistlich Pharma North America, Princeton, NJ
Classification
Class II
Status
Terminated
Recall initiated
19 Oct 2020
FDA classified
25 Nov 2020
Reported
2 Dec 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

19 Oct 2020Recall initiated by company
25 Nov 2020Classified by FDA+37 days
2 Dec 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Difficult to expel Geistlich Bio-Oss granules from the pen, resistance could suddenly drop, and the granules may be expelled all at once, causing surrounding tissue, particularly in use for the sinus lift indication and while unlikely, could pose a risk for patient harm, including irritation of the oral mucosa or even a perforation of the Schneiderian membrane

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Geistlich Bio-Oss Pen 0.25-1mm 0.25g - Product Usage: natural bone mineral for filling of bone defects in maxillofacial surgery, implantology, and periodontology. Product Number: 20115

Where it was distributed

Worldwide distribution - US Nationwide distribution and the country of Japan.

Nationwide

Questions about this recall

Is Geistlich Bio-Oss Pen 25 recalled?

Yes. Geistlich Pharma North America recalled Geistlich Bio-Oss Pen 25 on 19 Oct 2020. The recall is Class II and its status is Terminated. Recall number Z-0490-2021.

Why was it recalled?

Difficult to expel Geistlich Bio-Oss granules from the pen, resistance could suddenly drop, and the granules may be expelled all at once, causing surrounding tissue, particularly in use for the sinus lift indication and while unlikely, could pose a risk for patient harm, including irritation of the oral mucosa or even a perforation of the Schneiderian membrane

Which lots are affected?

Lots: 81901650, 82000456

Where was it sold?

Worldwide distribution - US Nationwide distribution and the country of Japan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Geistlich Pharma North America

All 6

Other Other Medical Devices recalls

All 13,778